TGTX Stock Alert: What to Know as Takeover Rumors Swirl Around TG Therapeutics
TG Therapeutics stock rips higher on takeover speculation. But should you chase the momentum on Friday? Let’s find out!
Barchart ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
MYSTERIOUS: Tg therapeutics | Mind Blowing Facts
Blue Owl Capital Q1 Earnings Call Highlights
Blue Owl Capital (NYSE:OBDC) reported first-quarter 2026 adjusted net investment income of $0.31 per share and net asset value per share of $14.41, as management said lower base rates, tighter spreads and reduced fee income weighed on earnings. Chief Executive Officer Craig Packer said the quarter
MarketBeat ·
TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback
TG Therapeutics Inc. (NASDAQ:TGTX) shares advanced Wednesday after the biopharmaceutical company announced the completion of a $100 million share repurchase program and unveiled plans for an additional $100 million buyback authorization.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Barchart
MarketBeat
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
